MicroRNAs' Impact on Heart Diseases

被引:0
作者
Cordeiro, Marco Antonio [1 ]
de Carvalho, Ana Elisa T. S. [1 ]
Spadari, Regina Celia [1 ]
机构
[1] Fed Univ Sao Paulo UNIFESP, Hlth & Soc Inst, Dept Biosci, Lab Stress Biol, Campus Baixada Santista, BR-11020015 Santos, SP, Brazil
基金
巴西圣保罗研究基金会;
关键词
cardiovascular diseases (CVDs); microRNAs (miRNAs); heart; epigenetics mechanisms; CIRCULATING MICRORNAS; NONCODING RNAS; CARDIOVASCULAR-DISEASE; CARDIAC-HYPERTROPHY; GENE-EXPRESSION; MESSENGER-RNAS; BIOGENESIS; MECHANISM; MIRNAS; CONDUCTION;
D O I
10.3390/ijms26125566
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cardiovascular diseases (CVDs) are the most prevalent cause of global mortality, highlighting the importance of understanding their molecular bases. Recently, small non-coding RNAs (miRNAS) were shown to affect messenger RNA (mRNA) stability, either by inhibiting translation or by causing degradation through base pairing with mRNAs, being negative regulators of protein translation. Moreover, miRNAs modulate many signaling pathways and cellular processes, including cell-to-cell communication. In the cardiovascular system, miRNAs control functions in cardiomyocytes, endothelial cells, smooth muscle cells, and fibroblasts. Because miRNA expression was detected in the blood of patients with various cardiovascular diseases, they are considered attractive candidates for noninvasive biomarkers. This study reviews the literature on the role played by miRNAs in heart development and diseases. The findings suggest that miRNA regulation may offer new perspectives for therapeutic interventions in heart diseases.
引用
收藏
页数:17
相关论文
共 130 条
[1]   Diversifying microRNA sequence and function [J].
Ameres, Stefan L. ;
Zamore, Phillip D. .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2013, 14 (08) :475-488
[2]   MicroRNAs: Small RNAs With Big Effects [J].
Anglicheau, Dany ;
Muthukumar, Thangamani ;
Suthanthiran, Manikkam .
TRANSPLANTATION, 2010, 90 (02) :105-112
[3]   Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma [J].
Arroyo, Jason D. ;
Chevillet, John R. ;
Kroh, Evan M. ;
Ruf, Ingrid K. ;
Pritchard, Colin C. ;
Gibson, Donald F. ;
Mitchell, Patrick S. ;
Bennett, Christopher F. ;
Pogosova-Agadjanyan, Era L. ;
Stirewalt, Derek L. ;
Tait, Jonathan F. ;
Tewari, Muneesh .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (12) :5003-5008
[4]   Let-7 in Cardiovascular Diseases, Heart Development and Cardiovascular Differentiation from Stem Cells [J].
Bao, Mei-Hua ;
Feng, Xing ;
Zhang, Yi-Wen ;
Lou, Xiao-Ya ;
Cheng, Yu ;
Zhou, Hong-Hao .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (11) :23086-23102
[5]   MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[6]   A carvedilol-responsive microRNA, miR-125b-5p protects the heart from acute myocardial infarction by repressing pro-apoptotic bak1 and klf13 in cardiomyocytes [J].
Bayoumi, Ahmed S. ;
Park, Kyoung-mi ;
Wang, Yongchao ;
Teoh, Jian-peng ;
Aonuma, Tatsuya ;
Tang, Yaoliang ;
Su, Huabo ;
Weintraub, Neal L. ;
Kim, Il-man .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2018, 114 :72-82
[7]   Role for a bidentate ribonuclease in the initiation step of RNA interference [J].
Bernstein, E ;
Caudy, AA ;
Hammond, SM ;
Hannon, GJ .
NATURE, 2001, 409 (6818) :363-366
[8]  
Blass I., 2022, MicroRNA, P69
[9]   Down-regulation of miR-133a/b in patients with myocardial infarction correlates with the presence of ventricular fibrillation [J].
Bostjancic, Emanuela ;
Brandner, Tanisa ;
Zidar, Nina ;
Glavac, Damjan ;
Stajer, Dusan .
BIOMEDICINE & PHARMACOTHERAPY, 2018, 99 :65-71
[10]   MicroRNAs Expression Profiles in Cardiovascular Diseases [J].
Bronze-da-Rocha, Elsa .
BIOMED RESEARCH INTERNATIONAL, 2014, 2014